Ferrari NV vs Roivant Sciences Ltd. Common Shares — how do they compare? Ferrari NV trades at $390.13 (market cap $67.35B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $24.72B). The key difference: Ferrari NV is far larger — about 2.7× Roivant Sciences Ltd. Common Shares's market cap, and Ferrari NV pays a 1.09% dividend while Roivant Sciences Ltd. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ferrari NV for 126 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| RACE | ROIV | |
|---|---|---|
Market Cap | $67.35B | $24.72B |
Volume | 390,618 | 6,279,442 |
Sector | Consumer Cyclical | Health |
52-Week High | $436.54 | $41.81 |
52-Week Low | $314.63 | $16.04 |
Typical Hold Time | 126 Days | 0 Days |
Enterprise Value | $69.22B | $20.99B |
Dividend Yield | 1.09% | — |
Signals from Pluang's Aura AI — not financial advice
Ferrari (RACE) trades at $386.39, down slightly by 0.03% today. The stock shows strong fundamentals with consistent earnings beats (Q4 2025: $2.49 vs. $2.44 expected, Q1 2026: $2.73 vs. $2.70 expected, Q2 2026: $2.99 vs. $2.83 expected) and robust profitability (net margin 22.25%, ROE 45.45%). Technical indicators are bearish overall, with the current price near support at $385. Recent news highlights a share buyback program and partnership with Rakuten effective January 2027.
Outlook: Analyst consensus is bullish with a $462.75 price target (73.69% buy ratings). Opportunities include strong brand equity, margin expansion, and strategic initiatives. Risks involve high valuation multiples (P/E 37.19, P/S 8.25), economic sensitivity, and execution of growth plans. The stock offers growth potential but requires monitoring of valuation and market conditions.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Ferrari engineers and manufactures some of the world's most expensive exotic sports cars. The Ferrari brand is synonymous with Formula One racing, exclusivity, Italian design, and state-of-the-art technology. Ferrari also has a captive finance company that provides funding for dealers and clients.
Read more on RACE →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →